FARALLON CAPITAL MANAGEMENT, L.L.C.
Institutional investor · Portfolio as of Q4 2025
Top Holdings154 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
STATE STREET SPDR S&P 500 ETF TRUST CL USD INC | 3M | $2B | 8.9% | — | — | — | Decreased — |
REVOLUTION MEDICINES INC | 14.6M | $1.2B | 5.0% | $35.04 | +127.38% | 20 qtrssince 2021-Q1 | Decreased 0 |
MICROSOFT CORP | 2.2M | $1.1B | 4.6% | $341.57 | +42.72% | 29 qtrssince 2018-Q4 | Increased 67 |
AMAZON.COM INC | 4.5M | $1B | 4.5% | $225.22 | +3.25% | 3 qtrssince 2025-Q2 | Increased 73 |
ELECTRONIC ARTS INC | 5M | $1B | 4.5% | $204.35 | 0.00% | 1 qtr | New 88 |
AON PLC | 2.7M | $940.5M | 4.1% | $329.96 | +6.67% | 8 qtrssince 2024-Q1 | Increased 68 |
NATERA INC | 3.9M | $896.7M | 3.9% | $74.46 | +208.88% | 19 qtrssince 2021-Q2 | Decreased 0 |
BOSTON SCIENTIFIC CORP | 7.4M | $709.4M | 3.1% | $73.83 | +30.05% | 22 qtrssince 2020-Q3 | Increased 82 |
INVESCO S&P 500 EQUAL WEIGHT | 3.6M | $689.6M | 3.0% | — | — | — | Decreased — |
EXELIXIS INC | 15.7M | $688.5M | 3.0% | $22.96 | +91.83% | 29 qtrssince 2018-Q4 | Decreased 0 |
BRIDGEBIO PHARMA INC | 9M | $688.3M | 3.0% | $37.53 | +101.11% | 6 qtrssince 2024-Q3 | Increased 60 |
EXACT SCIENCES CORP | 6.4M | $650.5M | 2.8% | $101.90 | — | 1 qtr | New 82 |
ISHR IBX USD HIYLD CB ETF-UI | 8M | $645M | 2.8% | — | — | — | Decreased — |
PROTAGONIST THERAPEUTICS INC | 6.1M | $536.6M | 2.3% | $19.34 | +351.27% | 29 qtrssince 2018-Q4 | Decreased 0 |
WABTEC CORP | 2.5M | $528.5M | 2.3% | $144.82 | +49.63% | 29 qtrssince 2018-Q4 | Increased 60 |
UNITEDHEALTH GROUP INC | 1.6M | $527.8M | 2.3% | $440.57 | -24.61% | 12 qtrssince 2023-Q1 | Decreased 0 |
CYBERARK SOFTWARE LTD | 1.1M | $469.7M | 2.0% | $451.32 | — | 1 qtr | New 81 |
WALT DISNEY CO/THE | 4.1M | $469.4M | 2.0% | $97.49 | +17.74% | 7 qtrssince 2024-Q2 | Decreased 0 |
SYNOPSYS INC | 999,200 | $469.3M | 2.0% | $474.49 | 0.00% | 1 qtr | New 81 |
ELI LILLY & CO | 375,000 | $403M | 1.7% | — | — | — | Unchanged — |
FARALLON CAPITAL MANAGEMENT, L.L.C. manages $23.1B across 154 positions as of Q4 2025. Top holdings: SPY (8.9%), RVMD (5.0%), MSFT (4.6%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 1.5/5.0.
Active quarter - 30 new positions, 21 exits, 22 increased. Top move: EA (NEW, conviction 88). Portfolio: $23.1B across 154 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer